| Autor: |
Salman, Reyhan Bilici, Koca, Gülce, Ateş, Seda Gülbahar, Yapar, Dilek, Babaoglu, Hakan, Satış, Hasan, Avanoglu Güler, Aslıhan, Karadeniz, Hazan, Ataş, Nuh, Küçük, Hamit, Akdemir, Ümit Özgür, Haznedaroğlu, Şeminur, Tufan, Abdurrahman, Göker, Berna, Paşaoğlu, Hatice, Atay, Lütfiye Özlem, Öztürk, Mehmet Akif |
| Předmět: |
|
| Zdroj: |
Modern Rheumatology; Sep2022, Vol. 32 Issue 5, p938-945, 8p |
| Abstrakt: |
Objectives: To investigate the association between vascular inflammation, as detected by positron emission tomography (PET) imaging and interleukin-6 (IL-6), pentraxin3, and B-cell-activating factor (BAFF) in subjects with LVV. Methods: The study included newly diagnosed giant cell arteritis (GCA, n=27) or Takayasu arteritis (n=9) patients and healthy control (HC, n=31) subjects. PET scan and blood samples were obtained before the introduction of treatments. IL-6, PTX3, and BAFF levels were determined quantitatively by enzyme-linked immunosorbent assay kits. Results: Thirty-six patients with LVV (20 females, 16 males; age 64.5±16.6 years) and 31 HC (14 females, 17 males; age 37.1±9.6 years) were included. Serum levels of IL-6, PTX3, and BAFF were increased in patients with newly diagnosed LVV compared with healthy control subjects. In receiver operating characteristics (ROC) analysis, serum IL-6 and BAFF provided excellent discrimination of newly diagnosed LVV patients from HC (area under the ROC curve of >0.90 and >0.80, respectively). None of the inflammatory markers correlated with vascular inflammatory activity determined by PET scanning. Conclusions: Our results suggest that IL-6 and BAFF may serve as markers of large vessel vasculitis, while PTX3 is not useful. None of the inflammatory markers correlated with PET assessed vasculitis activity. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
